Search research articles
Contact Us
Filters
Showing results (241-250 of 295) with videos related to
Page
of 30
Sort By:
Acta Neuropathologica
|
September 12, 2015
Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology
Emma L Clayton, Sarah Mizielinska, James R Edgar, et al.
Human Molecular Genetics
|
October 25, 2007
CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro
Julie van der Zee, Hazel Urwin, Sebastiaan Engelborghs, et al.
Molecular Cell
|
May 1, 2007
Disease-associated prion protein oligomers inhibit the 26S proteasome
Mark Kristiansen, Pelagia Deriziotis, Derek E Dimcheff, et al.
Plos One
|
March 9, 2010
Genetic variability in CLU and its association with Alzheimer's disease
Rita J Guerreiro, John Beck, J Raphael Gibbs, et al.
Communications Biology
|
July 31, 2020
Structural effects of the highly protective V127 polymorphism on human prion protein
Laszlo L P Hosszu, Rebecca Conners, Daljit Sangar, et al.
Brain : a Journal of Neurology
|
February 28, 2012
Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice
Shabnam Ghazi-Noori, Kristina E Froud, Sarah Mizielinska, et al.
Nature
|
June 11, 2015
A naturally occurring variant of the human prion protein completely prevents prion disease
Emmanuel A Asante, Michelle Smidak, Andrew Grimshaw, et al.
Brain : a Journal of Neurology
|
May 28, 2011
Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors
Diego N Kaski, Catherine Pennington, Jon Beck, et al.
Brain : a Journal of Neurology
|
February 28, 2012
Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features
Colin J Mahoney, Jon Beck, Jonathan D Rohrer, et al.
Molecular Psychiatry
|
March 6, 2021
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases
Andrew G B Thompson, Prodromos Anastasiadis, Ronald Druyeh, et al.
Page
of 30
Search research articles
Search
Showing results (241-250 of 295) with videos related to
Sort By:
Page
of 30
Acta Neuropathologica
|
September 12, 2015
Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology
Emma L Clayton, Sarah Mizielinska, James R Edgar, et al.
Human Molecular Genetics
|
October 25, 2007
CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro
Julie van der Zee, Hazel Urwin, Sebastiaan Engelborghs, et al.
Molecular Cell
|
May 1, 2007
Disease-associated prion protein oligomers inhibit the 26S proteasome
Mark Kristiansen, Pelagia Deriziotis, Derek E Dimcheff, et al.
Plos One
|
March 9, 2010
Genetic variability in CLU and its association with Alzheimer's disease
Rita J Guerreiro, John Beck, J Raphael Gibbs, et al.
Communications Biology
|
July 31, 2020
Structural effects of the highly protective V127 polymorphism on human prion protein
Laszlo L P Hosszu, Rebecca Conners, Daljit Sangar, et al.
Brain : a Journal of Neurology
|
February 28, 2012
Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice
Shabnam Ghazi-Noori, Kristina E Froud, Sarah Mizielinska, et al.
Nature
|
June 11, 2015
A naturally occurring variant of the human prion protein completely prevents prion disease
Emmanuel A Asante, Michelle Smidak, Andrew Grimshaw, et al.
Brain : a Journal of Neurology
|
May 28, 2011
Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors
Diego N Kaski, Catherine Pennington, Jon Beck, et al.
Brain : a Journal of Neurology
|
February 28, 2012
Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features
Colin J Mahoney, Jon Beck, Jonathan D Rohrer, et al.
Molecular Psychiatry
|
March 6, 2021
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases
Andrew G B Thompson, Prodromos Anastasiadis, Ronald Druyeh, et al.
Page
of 30